CAD 0.42
(-3.49%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 27.08 Million CAD | -21.71% |
2022 | 34.59 Million USD | 246.51% |
2021 | 9.98 Million CAD | -24.11% |
2020 | 13.15 Million CAD | 415.49% |
2019 | 2.55 Million CAD | -34.61% |
2018 | 3.9 Million CAD | 21.44% |
2017 | 3.21 Million CAD | 101.22% |
2016 | 1.59 Million CAD | -74.86% |
2015 | 6.35 Million CAD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q1 | 16.2 Million USD | -21.13% |
2024 Q2 | 12.76 Million USD | -21.24% |
2023 Q4 | 20.54 Million USD | -15.21% |
2023 Q1 | 30.41 Million USD | -12.07% |
2023 Q3 | 24.22 Million USD | -12.86% |
2023 FY | 27.08 Million CAD | -21.71% |
2023 Q2 | 27.8 Million USD | -8.61% |
2022 Q2 | 52.87 Million CAD | -5.14% |
2022 FY | 34.59 Million USD | 246.51% |
2022 Q1 | 55.74 Million CAD | 458.3% |
2022 Q3 | 51.18 Million CAD | -3.21% |
2022 Q4 | 34.59 Million USD | -32.4% |
2021 Q1 | 18.34 Million CAD | 39.45% |
2021 FY | 9.98 Million CAD | -24.11% |
2021 Q4 | 9.98 Million CAD | -24.46% |
2021 Q3 | 13.21 Million CAD | -23.74% |
2021 Q2 | 17.33 Million CAD | -5.52% |
2020 Q2 | 15.9 Million CAD | 362.12% |
2020 FY | 13.15 Million CAD | 415.49% |
2020 Q4 | 13.15 Million CAD | -3.78% |
2020 Q3 | 13.67 Million CAD | -14.02% |
2020 Q1 | 3.44 Million CAD | 34.83% |
2019 FY | 2.55 Million CAD | -34.61% |
2019 Q4 | 2.55 Million CAD | 0.0% |
2018 FY | 3.9 Million CAD | 21.44% |
2017 FY | 3.21 Million CAD | 101.22% |
2016 FY | 1.59 Million CAD | -74.86% |
2015 FY | 6.35 Million CAD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Therma Bright Inc. | 2.2 Million CAD | -1125.861% |
Theralase Technologies Inc. | 3.27 Million CAD | -726.593% |
VentriPoint Diagnostics Ltd. | 1.88 Million CAD | -1338.147% |